Doctoral Degree of Biological Science Programme, Faculty of Biology, Universitas Jenderal Soedirman Purwokerto, Indonesia.
Department of Anatomical Pathology PMN Cicendo Eye Hospital Bandung, Indonesia.
Asian Pac J Cancer Prev. 2022 Dec 1;23(12):4137-4143. doi: 10.31557/APJCP.2022.23.12.4137.
Visual disturbances that can heal after a complete resection of orbital meningiomas are only about 2.9%. Grading and expression of the progesterone receptor (PR) in orbital meningiomas, according to World Health Organization (WHO) is a useful predictive value of recurrence in the treatment management of orbital meningiomas. This study aims to determine the relationship of PR expression on the grading of orbital meningiomas as tumour prognostic factors.
This cross-sectional observational analysis observed 44 orbital meningioma in Cicendo Eye Hospital Bandung and Hasan Sadikin Hospital between 2017-2020. We performed of mRNA PR with RT-qPCR technique and calculation with the 2∆∆Ct formula. Statistical analysis used the Kruskal-Wallis Test, followed by the Mann-Whitney post hoc test with p<0.005.
Relative expression of mRNA PR in meningioma orbita grade I to grade III decreased significantly the expression of relative mRNA PR at grade I, II, III of 21.69±44.35, 20.39±26.30 and 1.25±0.85, with Kruskal-Wallis test, p =0.007. Mann Whitney's test results showed relative mRNA PR expression between grades I and II not different (p = 0.055), relative expression mRNA PR between grades I and III differed significantly (p = 0.024), and relative expression mRNA PR between grades I and III was not different (p = 0.638).
mRNA PR expression is viable for prognostic value, predicting recurrence and implementing more effective management of subsequent therapy, it must be combined with other markers to determine the nature of the orbital meningioma.
眼眶脑膜瘤完全切除后可自行愈合的视觉障碍仅约为 2.9%。根据世界卫生组织(WHO)的分级和孕激素受体(PR)表达,是预测眼眶脑膜瘤治疗管理中复发的有用价值。本研究旨在确定 PR 表达与眼眶脑膜瘤分级之间的关系,作为肿瘤预后因素。
本横断面观察性分析观察了 2017 年至 2020 年在万隆 Cicendo 眼科医院和万隆 Hasan Sadikin 医院的 44 例眼眶脑膜瘤。我们使用 RT-qPCR 技术进行 mRNA PR 检测,并使用 2∆∆Ct 公式进行计算。统计分析采用 Kruskal-Wallis 检验,然后进行 Mann-Whitney 事后检验,p<0.005。
眼眶脑膜瘤 I 级至 III 级的 PR mRNA 相对表达显著降低,I 级、II 级和 III 级的相对 PR mRNA 表达分别为 21.69±44.35、20.39±26.30 和 1.25±0.85,Kruskal-Wallis 检验,p=0.007。Mann Whitney 检验结果显示 I 级和 II 级之间的 PR mRNA 相对表达无差异(p=0.055),I 级和 III 级之间的 PR mRNA 相对表达有显著差异(p=0.024),而 I 级和 III 级之间的 PR mRNA 相对表达无差异(p=0.638)。
PR mRNA 表达具有预后价值,可预测复发,并实施更有效的后续治疗管理,但必须结合其他标志物来确定眼眶脑膜瘤的性质。